Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Noraylis Lorenzo"'
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 3, Pp 146-154
Rheumatoid arthritis is a degenerative disease characterized by chronic inflammation of peripheral joints. The first line of treatment involves the use of potent anti-inflammatory and immunosuppressive drugs, leading to an overall suppression of the
Externí odkaz:
https://doaj.org/article/e65915168637495f8c02fc8d751f3b38
Autor:
Ania Cabrales-Rico, Luis Javier González, Yassel Ramos, Yusimi Reyes, Hilda Garay, Osmel García, Yordanka Masforrol, Ana Marta López, Vladimir Besada, María Domínguez, Noraylis Lorenzo, Jorge Alexis, Dinhora Prada
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 143
CIGB-814, originally named as E18-3 APL1 or APL1 in preclinical experiments, is a novel therapeutic peptide candidate for Rheumatoid Arthritis (RA). It is an altered peptide ligand containing a novel CD4+ T-cell epitope of human heat shock protein 60
Autor:
Noraylis Lorenzo, F Altruda, O Reyes, J Ancizar, Isabel M. Hernandez, Rafael Gil, Gabriel Padrón, Ana María Torres, Maria Victoria Hernández, Ariana Barberá, L Silengo, Maria del Carmen Dominguez, H Garay
Publikováno v:
Autoimmunity. 45:449-459
Rheumatoid arthritis is a systemic autoimmune disease mediated by T cells. Productive engagement of T cell receptors by major histocompatibility complex-peptide leads to proliferation, differentiation and the definition of effector functions. Altered
Autor:
Guillaume Darrasse-Jèze, David Klatzmann, Rafael Gil, Maria Victoria Hernández, Ariana Barberá, Maria del Carmen Dominguez, Isabel M. Hernandez, Gabriel Padrón, Noraylis Lorenzo, Ana María Torres
Publikováno v:
Autoimmunity. 44(6)
Induction of immune tolerance as therapeutic approach for autoimmune diseases constitutes a current research focal point. In this sense, we aimed to evaluate an altered peptide ligand (APL) for induction of peripheral tolerance in patients with rheum
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 3, Pp 146-154
Rheumatoid arthritis is a degenerative disease characterized by chronic inflammation of peripheral joints. The first line of treatment involves the use of potent anti-inflammatory and immunosuppressive drugs, leading to an overall suppression of the
Autor:
Ariana Barberá, Ramón G Padrón, Yamile Heredia, María Domínguez, Elsy Chall, Lourdes Franco, Noraylis Lorenzo, Dolores Cantera, Amarys Alonso
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 9, Iss Suppl 1, p P182 (2011)
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal
Methods First, a novel T cell epitope from human heat-shock protein 60 (Hsp60), an autoantigen involved in the pathogenesis of JIA and other autoimmune diseases, was identified by bioinformatics tools and an APL was design starting from this epitope.